Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Aker Biomarine A
Its shares trade on Oslo Børs under the ticker AKBM.OL. It has been listed since 6 July 2020. In the fiscal year to 31 December 2025, it reported revenue of $218.1m and a net loss of $22.8m. At that date it held total assets of $384.9m and shareholders' equity of $143.9m.
Aker BioMarine AS operates as a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Food Products
- Listed since
- 6 Jul 2020
- Employees
- 626
- Website
- akerbiomarine.com ↗
Leadership
Pay as last reported
- Mr. Ola SnoveChairman of the Board, since 2014$76,037
- Mr. Matts JohansenChief Executive Officer, since 2015$1.0m
- Ms. Katrine KlavenessChief Financial Officer, since 2021$798,922
- Mr. Seth FrenchCEO - Lang Pharma Nutrition Inc$547,279
- Mr. Simon SewardCEO - Human Health Ingredients$477,625
- Mr. Trond SmedsrudCEO - Emerging Business, since 2024$399,806
- Ms. Hege SpaunChief Officer People and External Affairs$380,994
- Ms. Kristin HolmgrenDirector, Employee Representative
- Ms. Cilia IndahlDirector$33,328
- Ms. Kimberly MathisenDirector$33,328
- Mr. Frank ReiteDirector$44,665
- Mr. Jorn TungenDirector, Employee Representative
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 62
- Environment
- 69
- Social
- 93
- Governance
- 24
- Direct emissions (scope 1)
- 93,981 t
- Energy emissions (scope 2)
- 3,698 t
- Value chain emissions (scope 3)
- 13,166 t
- Women in the workforce
- 37.5%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Operates as a biotech innovator and Antarctic krill-harvesting company
- Has two business segments: Ingredients and Brands
- Focus on sustainability with AION by Aker BioMarine
Weaknesses
- IPO occurred in 2020-07-06
- Relies on krill harvesting which may face environmental concerns
- Limited to specific industry applications in nutraceutical and animal feed
Opportunities
- Expansion of krill-based ingredients in nutraceutical and aquaculture markets
- Growth potential in the US market through Epion Brands' Kori brand
- Circularity initiatives through AION by Aker BioMarine
Threats
- Environmental concerns related to krill harvesting
- Dependence on specific market segments for revenue
- Potential regulatory challenges in Antarctic harvesting
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.